This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Dec 17;373(25):2471-2.

doi: 10.1056/NEJMe1513258. Epub 2015 Nov 11.

Antidote for Factor Xa Anticoagulants

Jean M Connors¹

Affiliations

PMID: 26559124
DOI: 10.1056/NEJMe1513258

Editorial

Antidote for Factor Xa Anticoagulants

Jean M Connors. N Engl J Med. 2015.

. 2015 Dec 17;373(25):2471-2.

doi: 10.1056/NEJMe1513258. Epub 2015 Nov 11.

Author

Jean M Connors¹

Affiliation

¹ From the Hematology Division, Brigham and Women's Hospital, and Harvard Medical School - both in Boston.

PMID: 26559124
DOI: 10.1056/NEJMe1513258

No abstract available

PubMed Disclaimer

Comment on

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA. Siegal DM, et al. N Engl J Med. 2015 Dec 17;373(25):2413-24. doi: 10.1056/NEJMoa1510991. Epub 2015 Nov 11. N Engl J Med. 2015. PMID: 26559317 Clinical Trial.

Similar articles

[An antidote to the direct oral anticoagulants].
Wagner E. Wagner E. Rev Med Suisse. 2016 Jan 13;12(500):108. Rev Med Suisse. 2016. PMID: 26946718 French. No abstract available.
Anticoagulation therapy: Antidote to factor Xa inhibitors.
Lim GB. Lim GB. Nat Rev Cardiol. 2016 Jan;13(1):4. doi: 10.1038/nrcardio.2015.179. Epub 2015 Nov 26. Nat Rev Cardiol. 2016. PMID: 26606953 No abstract available.
Reversing anti-factor Xa agents and the unmet needs in trauma patients.
Hunt BJ, Neal MD, Stensballe J. Hunt BJ, et al. Blood. 2018 Dec 6;132(23):2441-2445. doi: 10.1182/blood-2018-06-850396. Epub 2018 Oct 11. Blood. 2018. PMID: 30309890 Review.
Throwing it in reverse: An update on reversal of oral factor Xa inhibitors.
Gilbert BW, Reeder JA, Alkhalifah MA, Moran DA, Corvino MA. Gilbert BW, et al. Am J Emerg Med. 2019 Oct;37(10):1978-1980. doi: 10.1016/j.ajem.2019.04.007. Epub 2019 Apr 8. Am J Emerg Med. 2019. PMID: 30987915 No abstract available.
Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors.
Nafee T, Aslam A, Chi G, Pahlavani S, Nimri D, Kuchkuntla AR, Talib U, Michalak N, Daaboul Y, Korjian S, Gallo A, Gibson CM. Nafee T, et al. Expert Rev Cardiovasc Ther. 2017 Apr;15(4):237-245. doi: 10.1080/14779072.2017.1305889. Epub 2017 Mar 22. Expert Rev Cardiovasc Ther. 2017. PMID: 28282497 Review.

See all similar articles

Cited by

Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study.
Behdarvand B, Karanges EA, Bero L. Behdarvand B, et al. BMJ Open. 2019 Aug 20;9(8):e030253. doi: 10.1136/bmjopen-2019-030253. BMJ Open. 2019. PMID: 31434780 Free PMC article.
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
Makam RCP, Hoaglin DC, McManus DD, Wang V, Gore JM, Spencer FA, Pradhan R, Tran H, Yu H, Goldberg RJ. Makam RCP, et al. PLoS One. 2018 May 24;13(5):e0197583. doi: 10.1371/journal.pone.0197583. eCollection 2018. PLoS One. 2018. PMID: 29795629 Free PMC article. Review.
Apixaban, concomitant medicines and spontaneous reports of haemorrhagic events.
Caughey GE, Kalisch Ellett LM, Barratt JD, Shakib S. Caughey GE, et al. Ther Adv Drug Saf. 2017 May;8(5):157-164. doi: 10.1177/2042098616689771. Epub 2017 Feb 10. Ther Adv Drug Saf. 2017. PMID: 28588761 Free PMC article.
Perioperative management of patients on direct oral anticoagulants.
Dubois V, Dincq AS, Douxfils J, Ickx B, Samama CM, Dogné JM, Gourdin M, Chatelain B, Mullier F, Lessire S. Dubois V, et al. Thromb J. 2017 May 15;15:14. doi: 10.1186/s12959-017-0137-1. eCollection 2017. Thromb J. 2017. PMID: 28515674 Free PMC article. Review.
New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism.
Kim JH, Lim KM, Gwak HS. Kim JH, et al. Biomol Ther (Seoul). 2017 Sep 1;25(5):461-470. doi: 10.4062/biomolther.2016.271. Biomol Ther (Seoul). 2017. PMID: 28365976 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information